publication date: Jun. 2, 2017

MD Anderson settles trademark litigation with Pelotonia, Soon-Shiong

By Paul Goldberg

MD Anderson Cancer Center has settled two separate trademark suits protecting the Houston-based cancer center’s Moonshot program.

One of the actions settled was filed against Pelotonia, a non-profit that coordinates a bike ride that raises money for The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard Solove Research Institute. MD Anderson claimed in a lawsuit that Pelotonia’s taglines “One Goal” and “One Goal: End Cancer” infringe the Houston cancer center’s trademark “One goal. Stop cancer” (The Cancer Letter, April 14).

The second suit was filed against Patrick Soon-Shiong, a pharmaceuticals billionaire. Until recently, his companies used the MoonShots2020 trademark. Though the details of the settlements weren’t discussed, they appear to be different. Pelotonia’s website continues to use the “One Goal” trademark, which is printed on t-shirts and jerseys. Soon-Shiong’s website no longer refers to moonshots.

Asked to comment on the Soon-Shiong litigation, MD Anderson officials issued a statement:

“The University of Texas MD Anderson Cancer Center has resolved its differences with Patrick Soon-Shiong, M.D., and his companies regarding the Moonshot and related trademarks. Dr. Soon-Shiong and his companies do not admit any fault or liability, and acknowledge MD Anderson has prior use and ownership of the Moonshot term in the fields of healthcare and charitable fundraising.   

“Dr. Soon-Shiong and his companies will use a different mark to avoid confusion and will abandon their applications to trademark Moonshot. As a result, MD Anderson is withdrawing its oppositions to such trademark applications.”

To announce resolution of their dispute, MD Anderson and Pelotonia said … Continue reading MD Anderson settles trademark litigation with Pelotonia, Soon-Shiong

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.